National Bank of Canada’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.25K | Sell |
473
-1,487
| -76% | -$10.2K | ﹤0.01% | 2203 |
|
|
2025
Q1 | $5.65K | Buy |
1,960
+1,500
| +326% | +$4.32K | ﹤0.01% | 2039 |
|
|
2024
Q4 | $2.16K | Hold |
460
| – | – | ﹤0.01% | 2197 |
|
|
2024
Q3 | $1.64K | Sell |
460
-4,000
| -90% | -$14.3K | ﹤0.01% | 2182 |
|
|
2024
Q2 | $28.1K | Buy |
4,460
+4,000
| +870% | +$25.2K | ﹤0.01% | 1715 |
|
|
2024
Q1 | $3.42K | Hold |
460
| – | – | ﹤0.01% | 2187 |
|
|
2023
Q4 | $3.31K | Hold |
460
| – | – | ﹤0.01% | 2217 |
|
|
2023
Q3 | $1.86K | Hold |
460
| – | – | ﹤0.01% | 2287 |
|
|
2023
Q2 | $1.52K | Hold |
460
| – | – | ﹤0.01% | 2332 |
|
|
2023
Q1 | $1.31K | Hold |
460
| – | – | ﹤0.01% | 2350 |
|
|
2022
Q4 | $3.34K | Hold |
460
| – | – | ﹤0.01% | 2233 |
|
|
2022
Q3 | $4K | Hold |
460
| – | – | ﹤0.01% | 2205 |
|
|
2022
Q2 | $2K | Hold |
460
| – | – | ﹤0.01% | 2378 |
|
|
2022
Q1 | $11K | Hold |
460
| – | – | ﹤0.01% | 2116 |
|
|
2021
Q4 | $8K | Buy |
+460
| New | +$8K | ﹤0.01% | 2189 |
|